Cambria Investment Management’s Merck MRK Stock Holding History

Cambria Investment Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$875K	Buy	7,270 +1,246	+21%	+$144K	0.05%	254
2025 Q4	$634K	Buy	+6,024	New	+$565K	0.04%	341
2019 Q4	–	Sell	-60,103	Closed	-$4.83M	–	215
2019 Q3	$4.83M	Sell	60,103 -729	-1%	-$58.4K	0.72%	59
2019 Q2	$4.87M	Buy	60,832 +826	+1%	+$63.2K	0.75%	51
2019 Q1	$4.76M	Buy	60,006 +964	+2%	+$72.1K	0.74%	45
2018 Q4	$4.3M	Sell	59,042 -10,734	-15%	-$758K	0.73%	42
2018 Q3	$4.72M	Sell	69,776 -1,729	-2%	-$110K	0.69%	40
2018 Q2	$4.23M	Sell	71,505 -12,328	-15%	-$695K	0.63%	67
2018 Q1	$4.36M	Sell	83,833 -23,241	-22%	-$1.26M	0.63%	73
2017 Q4	$5.75M	Buy	107,074 +24,366	+29%	+$1.35M	0.8%	66
2017 Q3	$5.05M	Buy	82,708 +5,271	+7%	+$320K	0.78%	60
2017 Q2	$4.74M	Buy	+77,437	New	+$4.71M	1.02%	32

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cambria Investment Management's MRK Position: Q1 2026 in Review

Cambria Investment Management increased its Merck (MRK) stake by 21% in Q1 2026, buying an estimated $144K and bringing the position to 7,270 shares worth $875K. The position accounts for 0.05% of the portfolio, ranked #254.

Cambria Investment Management first reported a position in MRK in Q2 2017 and has held it in 12 quarters since. The position peaked at $5.75M in Q4 2017. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Cambria Investment Management held 7,270 shares of Merck worth $875K as of Q1 2026.
Cambria Investment Management bought 1,246 Merck shares in Q1 2026, an estimated $144K.
Merck made up 0.05% of Cambria Investment Management's portfolio in Q1 2026, its #254 holding.
Cambria Investment Management first reported a position in Merck in Q2 2017 and has held it in 12 quarters since.
Cambria Investment Management's Merck position peaked at $5.75M in Q4 2017.
3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Cambria Investment Management's 13F filing for Q1 2026, filed 15 May 2026.